GlassScriptPhysician profile
Carla Soler
NPI 1407836687
$2,275.87
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $438 · 2022: $729 · 2023: $611 · 2024: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,109.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $371.21 | 2021-2024 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $322.45 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.83 | 2021-2024 | Tradjenta, Jardiance |
| Abbvie INC. | $150.85 | 2021-2024 | Ubrelvy |
| Amgen INC. | $130.34 | 2021-2023 | Prolia, Evenity |
| Astrazeneca Pharmaceuticals LP | $120.90 | 2021-2024 | Farxiga |
| Glaxosmithkline, LLC. | $88.74 | 2023-2024 | Arexvy, Shingrix |
| Biohaven Pharmaceutical Holding Company LTD. | $83.84 | 2022 | |
| Pfizer INC. | $80.47 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $73.12 | 2021-2022 | |
| Exact Sciences Corporation | $64.91 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $61.57 | 2024 | Veozah |
| Organon LLC | $57.49 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $46.54 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.05 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $38.55 | 2021-2022 | |
| Harmony Biosciences LLC | $34.16 | 2022 | |
| Tactile Systems Technology INC | $32.41 | 2021-2022 | |
| Abbott Laboratories | $29.34 | 2023 | Freestyle Libre 3 |
| Edwards Lifesciences Corporation | $24.05 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biohaven Pharmaceuticals, INC. | $22.04 | 2021 | |
| Vivus LLC | $20.66 | 2022 | |
| Daiichi Sankyo INC. | $20.00 | 2022 | |
| Sanofi Pasteur INC. | $19.95 | 2023 | |
| Galderma Laboratories, L.P. | $19.51 | 2021 | |
| Irhythm Technologies, INC. | $19.14 | 2024 | Zio Monitor, Zio Xt Patch |
| Kowa Pharmaceuticals America, INC. | $18.39 | 2022 | |
| Shield Therapeutics INC | $18.35 | 2023 | Accrufer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.40 | 2023 | Xifaxan |
| Biogen, INC. | $16.38 | 2022 | |
| Impel Pharmaceuticals INC. | $14.84 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.69 | 2021 | |
| Acerus Pharmaceuticals Corporation | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Soler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.